Skip to content

The antianxiety or hypnotic medication quality measure (N036.03)

N0415B1 and D1 in the 7-day look-back decide it. How N036 differs from the surveyor-only N033, who is excluded, and why you code the drug class, not the use.

September 29, 2026 · 4 min read · SuperLTC

The long-stay antianxiety or hypnotic medication measure counts residents who received either class of drug in the 7 days before the ARD of their most recent assessment. It is on Care Compare, it isn’t in Five-Star, and both Texas and Florida score it.

Two measures, one set of items

CMS calculates two long-stay measures from the same checkboxes, and they are easy to mix up:

MeasureWhere it’s reportedWho is excluded
N036.03 Percent of residents who used antianxiety or hypnotic medicationCare Compare, iQIES reports. Scored by Texas QIPP and Florida QIP.Life expectancy under 6 months (J1400) or hospice (O0110K1b)
N033.03 Prevalence of antianxiety/hypnotic useiQIES reports only, for state surveyorsSchizophrenia, psychotic disorder, bipolar disorder, Tourette’s, Huntington’s, hallucinations, delusions, anxiety disorder or PTSD

The difference matters. A resident with an anxiety disorder checked at I5700 is left out of N033, but still counts in N036, the measure on Care Compare and the one the states pay on.

“This measure is a state surveyor measure and is not part of NHQI. As such, it is not reported on Care Compare on Medicare.gov and is only available on the iQIES QM reports.”
MDS 3.0 QM User’s Manual v18.0, Chapter 2, Table 2-33, footnote 35, page 52

What puts a resident in the numerator

“This measure reports the prevalence of antianxiety or hypnotic medication use (long-stay) during the target period.”
MDS 3.0 QM User’s Manual v18.0, Chapter 2, Table 2-28, page 43

On the target assessment, N0415B1 (antianxiety) or N0415D1 (hypnotic) is checked. Column 2, the indication, plays no part in the measure. A resident with a well-documented reason for the drug counts the same as one without.

For N036.03, the resident is left out of the denominator when:

  • life expectancy of less than 6 months is coded (J1400 = 1), or
  • the resident received hospice care while a resident (O0110K1b = 1), or
  • the resident isn’t in the numerator and N0415B1 or N0415D1 is dashed.

There is no risk adjustment.

The 7-day look-back, and when it clears

N0415 is checked if the drug was taken at any time in the 7-day look-back (or since entry, if that’s shorter). One dose is enough: a single PRN in the window checks the box. So does a dose given anywhere while the person is a resident, by any route, including the emergency room.

The measure looks only at the target assessment, the resident’s latest qualifying assessment. If the prescriber and team take a resident off the drug, it stops counting once a target assessment has a look-back with no dose in it. The drug decision is a clinical one. The MDS only records what was given.

A worked example. Resident B has a PRN order for an antianxiety drug and got one dose, four days before the ARD of the quarterly that is Resident B’s target assessment. N0415B1 is checked, and Resident B is in the N036 numerator. Resident B also has an anxiety disorder checked at I5700, so N033 leaves Resident B out. The surveyor report and Care Compare tell two different stories about the same dose.

Code the class, not the use

Most errors in N0415B and D come from coding a drug by why it was given rather than by what it is.

“Code medications in Item N0415 according to the medication’s therapeutic category and/or pharmacological classification, not how it is used. For example, although oxazepam may be prescribed for use as a hypnotic, it is categorized as an antianxiety medication.”
RAI Manual v1.20.11, Chapter 3, Section N, page N-8
  • A drug with two classifications is coded in both. Check the package insert, or ask the pharmacist, and keep a consistent reference so the coder can show the source.
  • Supplements aren’t medications. Herbal and alternative products such as melatonin, chamomile and valerian root are not coded in N0415.
  • Over-the-counter sleep aids aren’t hypnotics.
“Over-the-counter sleeping medications are not coded as hypnotics, as they are not categorized as hypnotic medications.”
RAI Manual v1.20.11, Chapter 3, Section N, page N-9

The documentation that supports the code is the MAR for the 7 days, plus any record of a dose given outside the building while the person was a resident. When the MAR and the MDS disagree, fix it before the assessment is submitted.

How the states use it

See your building’s antianxiety and hypnotic rate against the nation, free.

SuperQM scores both N036 and N033 from each resident’s latest assessment, so you can see who counts in each before the quarter closes.

See where your building stands.

Your stars, your measures and your state program. Free, from public data.

Rather talk first? Book 20 minutes